An eight-gene blood expression profile predicts the response to infliximab in rheumatoid arthritis.
about
Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signalingPersonalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicabilityGene expression analysis in RA: towards personalized medicineCD4(+)CD25(+) regulatory T cells as a therapeutic target in rheumatoid arthritisCausal modeling using network ensemble simulations of genetic and gene expression data predicts genes involved in rheumatoid arthritisA novel method predicting clinical response using only background clinical data in RA patients before treatment with infliximab.Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease.Pharmacogenetics and pharmacogenomics in rheumatology.Functional genomics and rheumatoid arthritis: where have we been and where should we go?Validation study of existing gene expression signatures for anti-TNF treatment in patients with rheumatoid arthritisDivergent gene activation in peripheral blood and tissues of patients with rheumatoid arthritis, psoriatic arthritis and psoriasis following infliximab therapy.Pre-treatment whole blood gene expression is associated with 14-week response assessed by dynamic contrast enhanced magnetic resonance imaging in infliximab-treated rheumatoid arthritis patientsAn empirical assessment of validation practices for molecular classifiersEvaluation of gene expression classification studies: factors associated with classification performanceTherapeutic cancer vaccines and translating vaccinomics science to the global health clinic: emerging applications toward proof of conceptCurrent and future trends in biomarker discovery and development of companion diagnostics for arthritis.Blood-based identification of non-responders to anti-TNF therapy in rheumatoid arthritis.Modular analysis of peripheral blood gene expression in rheumatoid arthritis captures reproducible gene expression changes in tumor necrosis factor responders.The gene expression profile of preclinical autoimmune arthritis and its modulation by a tolerogenic disease-protective antigenic challengeApplying refinement to the use of mice and rats in rheumatoid arthritis research.Pregnancy-Induced Changes in Systemic Gene Expression among Healthy Women and Women with Rheumatoid Arthritis.Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study.Crohn's disease genotypes of patients in remission vs relapses after infliximab discontinuation.Investigating CD11c expression as a potential genomic biomarker of response to TNF inhibitor biologics in whole blood rheumatoid arthritis samples.Profiling the immune stromal interface in breast cancer and its potential for clinical impactWhole blood gene expression analyses in patients with single versus recurrent venous thromboembolism.Microarray analysis reveals the molecular basis of antiarthritic activity of huo-luo-xiao-ling dan.Identification of baseline gene expression signatures predicting therapeutic responses to three biologic agents in rheumatoid arthritis: a retrospective observational studyIntegration of known DNA, RNA and protein biomarkers provides prediction of anti-TNF response in rheumatoid arthritis: results from the COMBINE study.Cytokines as biomarkers in rheumatoid arthritis.Clinical application and evaluation of anti-TNF-alpha agents for the treatment of rheumatoid arthritis.Rheumatoid arthritis pharmacogenomics.Biomarkers for rheumatoid arthritis: making it personal.Genetic and genomic predictors of anti-TNF response.The potential use of expression profiling: implications for predicting treatment response in rheumatoid arthritis.Combining genetic and nongenetic biomarkers to realize the promise of pharmacogenomics for inflammatory diseases.Screening Feature Genes of Venous Thromboembolism with DNA Microarray.Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritis.Gene Expression Signatures and the Spectrum of Coronary Artery Disease.Detection of gene expression signatures related to underlying disease and treatment in rheumatoid arthritis patients.
P2860
Q24312041-5E10E762-310A-4B3F-8775-ADB404A9AD57Q26771652-74564ECF-D6FE-49D5-B1AF-D7D7A090B368Q26825706-F8C5A2E8-ACD8-4B63-A203-BB22CB28CCC6Q27024365-80B81A41-75D6-4DAB-809D-B152C8BAD66DQ28477388-94007A1D-EF79-4DF4-9973-726E612F3CD1Q31090628-2BF8E221-ABBF-4DBD-95BD-69C40F4E24FCQ33781056-8D063592-A3E3-40A9-BFD2-C47B2A78B7C4Q34070615-5A75A1E0-2D72-4561-9DC1-5A657A6D5E5BQ34073498-23ACFDB5-540F-4238-8173-D039EEFD4716Q34211769-AA455B27-5057-4643-8826-1F07F9FD1DD0Q34380190-4604A13F-F1AA-406F-B3B8-93541A33E5BCQ34688901-FAAFC527-2CD4-46DD-9EEE-D4F337B1A25BQ34933977-7AF69FB2-7141-45AC-BD06-C8A7193C54ADQ35158226-4C5123B2-2A34-43EF-966A-A98F9461D13CQ35193892-438E1D03-DDA5-4622-85EF-A5252685F722Q35470652-F5CA2899-EBD9-4BA7-84BE-C57DF6243D14Q35650155-4F738C30-9057-4306-9981-4A04BD544FDBQ35766221-6E83124E-880C-4768-B2DD-AC11B3C03364Q35840722-D60FB0E4-9686-43FA-8542-F7A836493291Q35868533-C4651CEE-39C1-4BA3-A30F-CC795C47EA12Q35873131-8FF26ACA-217C-43C0-B366-8FE93138334BQ36213507-04D6C0B3-B113-41FC-B760-D726A21EAEE4Q36285782-113D9582-B2BB-4C70-8198-72035CF57262Q36439978-D7A6F6D4-F350-4D49-B42C-463E60593E3AQ36449295-464F8CF8-534F-43E1-9912-6632C7E6E9E2Q37054105-5828AB37-14AE-43AA-880E-A8912C974F99Q37101023-4AC9F26E-E5D3-468C-9951-2F9105B5273AQ37111423-3E7A93FC-8596-4900-B411-CED0CC3CB078Q37256337-ADC90B7D-DDB3-46FD-B097-7A6794DD43C9Q37661549-42D59E1C-1D60-497E-B4DB-6A5E677891DAQ37728019-6F772AD4-3FFE-4BDF-B8AD-4B26E7BC292FQ37736447-82573052-A453-4C17-AB1E-561FC57734CCQ37761911-8119CCF2-C4BD-4332-BB53-A29C228FBB2FQ37951648-487909D2-C918-47BE-A589-EA24DEFCCD6FQ38088942-DC066A04-BD1D-4DC7-A763-4D5422FAA0DEQ38286234-E0088D35-6C46-40F4-B18C-406757417F57Q38300411-45536266-29FC-4447-BC19-8F3E6BD16559Q38529234-5353264C-2BC4-40A6-A210-4C6B7EE2BA76Q38531858-C6653B57-BEA3-49D1-8D82-46345AC2A095Q39572838-DDE88B49-A637-488F-A9D7-AD7F3E3FA010
P2860
An eight-gene blood expression profile predicts the response to infliximab in rheumatoid arthritis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
An eight-gene blood expression ...... ximab in rheumatoid arthritis.
@ast
An eight-gene blood expression ...... ximab in rheumatoid arthritis.
@en
An eight-gene blood expression ...... ximab in rheumatoid arthritis.
@nl
type
label
An eight-gene blood expression ...... ximab in rheumatoid arthritis.
@ast
An eight-gene blood expression ...... ximab in rheumatoid arthritis.
@en
An eight-gene blood expression ...... ximab in rheumatoid arthritis.
@nl
prefLabel
An eight-gene blood expression ...... ximab in rheumatoid arthritis.
@ast
An eight-gene blood expression ...... ximab in rheumatoid arthritis.
@en
An eight-gene blood expression ...... ximab in rheumatoid arthritis.
@nl
P2093
P2860
P1433
P1476
An eight-gene blood expression ...... iximab in rheumatoid arthritis
@en
P2093
Antonio Julià
Carlos Tomas
Pere Barceló
Sara Marsal
Xavier Sans
P2860
P356
10.1371/JOURNAL.PONE.0007556
P407
P577
2009-10-22T00:00:00Z